相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA-directed assembly of copper nanoblocks with inbuilt fluorescent and electrochemical properties: Application in simultaneous amplification-free analysis of multiple RNA species
Kevin M. Koo et al.
NANO RESEARCH (2018)
Design and Clinical Verification of Surface Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction
Kevin M. Koo et al.
ACS NANO (2018)
Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device
Changqing Yin et al.
ANALYTICAL CHEMISTRY (2018)
Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease
Martina Mijuskovic et al.
BRITISH JOURNAL OF CANCER (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening
James T. Kearns et al.
CANCER (2018)
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A. Quigley et al.
CELL (2018)
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
Cheng Zong et al.
CHEMICAL REVIEWS (2018)
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
Peter Strom et al.
EUROPEAN UROLOGY (2018)
Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features
R. Jeffrey Karnes et al.
EUROPEAN UROLOGY (2018)
Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement
David C. Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
NATURE GENETICS (2018)
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
David C. Wedge et al.
NATURE GENETICS (2018)
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Maha Hussain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
V Kasivisvanathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Amplification-Free Multi-RNA-Type Profiling for Cancer Risk Stratification via Alternating Current Electrohydrodynamic Nanomixing
Kevin M. Koo et al.
SMALL (2018)
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2018)
A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification
Sherif Mehralivand et al.
JAMA ONCOLOGY (2018)
Mix-to-Go Silver Colloidal Strategy for Prostate Cancer Molecular Profiling and Risk Prediction
Jing Wang et al.
ANALYTICAL CHEMISTRY (2018)
A Sample-to-Targeted Gene Analysis Biochip for Nanofluidic Manipulation of Solid-Phase Circulating Tumor Nucleic Acid Amplification in Liquid Biopsies
Kevin M. Koo et al.
ACS SENSORS (2018)
Extended Mortality Results for Prostate Cancer Screening in the PLCO Trial With Median Follow-Up of 15 Years
Paul F. Pinsky et al.
CANCER (2017)
A Prostate Cancer Nimbosus'': Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
Melvin L. K. Chua et al.
EUROPEAN UROLOGY (2017)
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
Rong Na et al.
EUROPEAN UROLOGY (2017)
The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics
Christopher E. Barbieri et al.
EUROPEAN UROLOGY (2017)
Novel biomarkers for prostate cancer: An evidence-based review for use in clinical practice
Vikram M. Narayan et al.
INTERNATIONAL JOURNAL OF UROLOGY (2017)
The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer An Invitation to Review and Comment
Kirsten Bibbins-Domingo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E. Spratt et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Chemistry-Driven Approaches for Ultrasensitive Nucleic Acid Detection
Sarah J. Smith et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
EEnabling miniaturised personalised diagnostics: from lab-on-a-chip to lab-in-a-drop
Kevin M. Koo et al.
LAB ON A CHIP (2017)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U. Ahmed et al.
LANCET (2017)
A nanoplasmonic label-free surface-enhanced Raman scattering strategy for non-invasive cancer genetic subtyping in patient samples
Jing Wang et al.
NANOSCALE (2017)
ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis
Rohit Bose et al.
NATURE (2017)
Integrative clinical genomics of metastatic cancer
Dan R. Robinson et al.
NATURE (2017)
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser et al.
NATURE (2017)
TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
Ken J. Kron et al.
NATURE GENETICS (2017)
Prostate Cancer Screening - A Perspective on the Current State of the Evidence
Paul F. Pinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
N. D. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inference for multimarker adaptive enrichment trials
Richard Simon et al.
STATISTICS IN MEDICINE (2017)
Prognostic utility of biopsy-derived cell cycle progression score in patients with National Comprehensive Cancer Network low-risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance
Jeffrey J. Tosoian et al.
BJU INTERNATIONAL (2017)
Urinary biomarkers in prostate cancer detection and monitoring progression
Duojia Wu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
Alex Tsodikov et al.
ANNALS OF INTERNAL MEDICINE (2017)
Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer
Ziyi Cheng et al.
ACS NANO (2017)
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
Xiaoju Wang et al.
CANCER CELL (2017)
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer
Thomas U. Ahearn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer
Stephen J. Murphy et al.
MODERN PATHOLOGY (2016)
The oncogene ERG: a key factor in prostate cancer
P. Adamo et al.
ONCOGENE (2016)
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer
Thomas U. Ahearn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Amplification-Free Detection of Gene Fusions in Prostate Cancer Urinary Samples Using mRNA-Gold Affinity Interactions
Kevin M. Koo et al.
ANALYTICAL CHEMISTRY (2016)
Poly(A) Extensions of miRNAs for Amplification-Free Electrochemical Detection on Screen-Printed Gold Electrodes
Kevin M. Koo et al.
ANALYTICAL CHEMISTRY (2016)
Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression
Douglas E. Linn et al.
CANCER RESEARCH (2016)
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review
Francesca Sanguedolce et al.
CLINICAL GENITOURINARY CANCER (2016)
Molecular subtyping of prostate cancer
Samuel D. Kaffenberger et al.
CURRENT OPINION IN UROLOGY (2016)
The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These Cancers
Giorgio Gandaglia et al.
EUROPEAN UROLOGY (2016)
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2016)
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score
Leander Van Neste et al.
EUROPEAN UROLOGY (2016)
A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort
Katharina Braun et al.
EUROPEAN UROLOGY (2016)
Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer
Rohit Mehra et al.
EUROPEAN UROLOGY (2016)
Rapid and Sensitive Fusion Gene Detection in Prostate Cancer Urinary Specimens by Label-Free Surface-Enhanced Raman Scattering
Kevin M. Koo et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
Large scale synthesis of surface-enhanced Raman scattering nanoprobes with high reproducibility and long-term stability
Hyung-Mo Kim et al.
JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY (2016)
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar et al.
NATURE MEDICINE (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Translational and clinical implications of the genetic landscape of prostate cancer
Daniel E. Spratt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Personalized risk-stratified screening or abandoning it altogether?
Sigrid V. Carlsson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Reevaluating PSA Testing Rates in the PLCO Trial
Jonathan E. Shoag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies
Leander Van Neste et al.
PROSTATE (2016)
Increasing incidence of metastatic prostate cancer in the United States (2004-2013)
A. B. Weiner et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Toward Precision Medicine: A Cancer Molecular Subtyping Nano-Strategy for RNA Biomarkers in Tumor and Urine
Kevin M. Koo et al.
SMALL (2016)
Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk
Eric A. Klein et al.
UROLOGY (2016)
Colorimetric TMPRSS2-ERG Gene Fusion Detection in Prostate Cancer Urinary Samples via Recombinase Polymerase Amplification
Kevin M. Koo et al.
THERANOSTICS (2016)
Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer
Ram S. Mani et al.
CELL REPORTS (2016)
An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer
Vivekananda Kedage et al.
CELL REPORTS (2016)
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Alexander W. Wyatt et al.
JAMA ONCOLOGY (2016)
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
James McKiernan et al.
JAMA ONCOLOGY (2016)
Integrative molecular profiling of routine clinical prostate cancer specimens
C. S. Grasso et al.
ANNALS OF ONCOLOGY (2015)
Prioritizing precision medicine for prostate cancer
G. Attard et al.
ANNALS OF ONCOLOGY (2015)
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
Andrej Jedinak et al.
BMC CANCER (2015)
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
S. Salvi et al.
BRITISH JOURNAL OF CANCER (2015)
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
Elizabeth A. Punnoose et al.
BRITISH JOURNAL OF CANCER (2015)
Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy
Selin Merdan et al.
CANCER (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence
Alyssa B. Chinen et al.
CHEMICAL REVIEWS (2015)
Universal One-Pot and Scalable Synthesis of SERS Encoded Nanoparticles
Bernat Mir-Simon et al.
CHEMISTRY OF MATERIALS (2015)
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
Gisele H. J. M. Leyten et al.
CLINICAL CANCER RESEARCH (2015)
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A. Azad et al.
CLINICAL CANCER RESEARCH (2015)
Genomic rearrangements in prostate cancer
Christopher E. Barbieri et al.
CURRENT OPINION IN UROLOGY (2015)
A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer
Dipen J. Parekh et al.
EUROPEAN UROLOGY (2015)
A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
Jennifer Cullen et al.
EUROPEAN UROLOGY (2015)
Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2015)
A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy
Eric A. Klein et al.
EUROPEAN UROLOGY (2015)
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
Jurgen J. Futterer et al.
EUROPEAN UROLOGY (2015)
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
Ahmedin Jemal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations
Jesse D. Sammon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
M. Minhaj Siddiqui et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer
Kosj Yamoah et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naive Men
Claire de la Calle et al.
JOURNAL OF UROLOGY (2015)
Ultrasensitive Prostate Specific Antigen and its Role after Radical Prostatectomy: A Systematic Review
Derya Tilki et al.
JOURNAL OF UROLOGY (2015)
The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
Stacy Loeb et al.
JOURNAL OF UROLOGY (2015)
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Henrik Gronberg et al.
LANCET ONCOLOGY (2015)
The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition
Payel Chatterjee et al.
MOLECULAR CANCER THERAPEUTICS (2015)
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem et al.
NATURE (2015)
A basal stem cell signature identifies aggressive prostate cancer phenotypes
Bryan A. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Identification of prostate cancer biomarkers in urinary exosomes
Anders Overbye et al.
ONCOTARGET (2015)
Landscape of gene fusions in epithelial cancers: seq and ye shall find
Chandan Kumar-Sinha et al.
GENOME MEDICINE (2015)
Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
Ketan K. Badani et al.
BJU INTERNATIONAL (2015)
Rapid and Quantitative Detection of Prostate Specific Antigen with a Quantum Dot Nanobeads-Based Immunochromatography Test Strip
Xue Li et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Clinical use of novel urine and blood based prostate cancer biomarkers: A review
S. Dijkstra et al.
CLINICAL BIOCHEMISTRY (2014)
Prostate Cancer SubtyPINg BiomarKers and Outcome: Is Clarity EmERGing?
Steven C. Smith et al.
CLINICAL CANCER RESEARCH (2014)
Biomarkers in prostate cancer: what's new?
David A. Sartori et al.
CURRENT OPINION IN ONCOLOGY (2014)
Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer
Kathryn E. Ware et al.
ENDOCRINE-RELATED CANCER (2014)
Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound-Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies
Morgan R. Pokorny et al.
EUROPEAN UROLOGY (2014)
A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
Eric A. Klein et al.
EUROPEAN UROLOGY (2014)
Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
Gisele H. J. M. Leyten et al.
EUROPEAN UROLOGY (2014)
TMPRSS:ERG Fusion in Prostate Cancer: From Experimental Approaches to Prognostic Studies
Zoran Culig
EUROPEAN UROLOGY (2014)
Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
John T. Wei et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
TMPRSS2:ERG Gene Fusion Predicts Subsequent Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia
Kyung Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies
Alan W. Partin et al.
JOURNAL OF UROLOGY (2014)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H. Schroder et al.
LANCET (2014)
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
John R. Prensner et al.
LANCET ONCOLOGY (2014)
Prevention and early detection of prostate cancer
Jack Cuzick et al.
LANCET ONCOLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c
J. Kim et al.
ONCOGENE (2014)
Identification of novel TMPRSS2: ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2
T. V. Tian et al.
ONCOGENE (2014)
Mechanisms of the androgen receptor splicing in prostate cancer cells
L. L. Liu et al.
ONCOGENE (2014)
Tumor clone dynamics in lethal prostate cancer
Suzanne Carreira et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
Jared M. Lucas et al.
CANCER DISCOVERY (2014)
Urinary biomarkers for prostate cancer: a review
Daphne Hessels et al.
ASIAN JOURNAL OF ANDROLOGY (2013)
Adaptive enrichment designs for clinical trials
Noah Simon et al.
BIOSTATISTICS (2013)
Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer
Haydn Thomas Kissick et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
ERG Is a Critical Regulator of Wnt/LEF1 Signaling in Prostate Cancer
Longtao Wu et al.
CANCER RESEARCH (2013)
Recurrent Rearrangements in Prostate Cancer: Causes and Therapeutic Potential
Nicole M. White et al.
CURRENT DRUG TARGETS (2013)
The Mutational Landscape of Prostate Cancer
Christopher E. Barbieri et al.
EUROPEAN UROLOGY (2013)
Image-Guided Prostate Biopsy Using Magnetic Resonance Imaging-Derived Targets: A Systematic Review
Caroline M. Moore et al.
EUROPEAN UROLOGY (2013)
Current Status of Biomarkers for Prostate Cancer
Vicki M. Velonas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Automated Multiplexing Quantum Dots in Situ Hybridization Assay for Simultaneous Detection of ERG and PTEN Gene Status in Prostate Cancer
Wenjun Zhang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study
Grant D. Stewart et al.
JOURNAL OF UROLOGY (2013)
PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study
Marc C. Gittelman et al.
JOURNAL OF UROLOGY (2013)
Early Detection of Prostate Cancer: AUA Guideline
H. Ballentine Carter et al.
JOURNAL OF UROLOGY (2013)
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
John R. Prensner et al.
NATURE GENETICS (2013)
A Molecular Signature Predictive of Indolent Prostate Cancer
Shazia Irshad et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
Simpa S. Salami et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group
Ketan Badani et al.
ONCOTARGET (2013)
Recurrent Gene Fusions in Prostate Cancer: Their Clinical Implications and Uses
Daphne Hessels et al.
CURRENT UROLOGY REPORTS (2013)
Genomic rearrangements of PTEN in prostate cancer
Sopheap Phin et al.
FRONTIERS IN ONCOLOGY (2013)
Correlation of Urine TMPRSS2:ERG and PCA3 to ERG plus and Total Prostate Cancer Burden
Allison Young et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
Antje Krohn et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling
Luciana Bueno Ferreira et al.
BMC CANCER (2012)
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2012)
Translational genomics: The challenge of developing cancer biomarkers
James D. Brooks
GENOME RESEARCH (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
Gerald L. Andriole et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Commercialization of microfluidic point-of-care diagnostic devices
Curtis D. Chin et al.
LAB ON A CHIP (2012)
The Epigenetic promise for prostate cancer diagnosis
Leander Van Neste et al.
PROSTATE (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
John R. Prensner et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Molecular Subtyping of Primary Prostate Cancer Reveals Specific and Shared Target Genes of Different ETS Rearrangements
Paula Paulo et al.
NEOPLASIA (2012)
Markers of Field Cancerization: Proposed Clinical Applications in Prostate Biopsies
Kristina A. Trujillo et al.
PROSTATE CANCER (2012)
Fluorescent-Magnetic-Biotargeting Multifunctional Nanobioprobes for Detecting and Isolating Multiple Types of Tumor Cells
Er-Qun Song et al.
ACS NANO (2011)
Positive Potential Operation of a Cathodic Electrogenerated Chemiluminescence Immunosensor Based on Luminol and Graphene for Cancer Biomarker Detection
Shoujiang Xu et al.
ANALYTICAL CHEMISTRY (2011)
PCA3: From basic molecular science to the clinical lab
John R. Day et al.
CANCER LETTERS (2011)
Androgen receptor and its splice variants in prostate cancer
Simon Haile et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance
Guillaume Ploussard et al.
EUROPEAN UROLOGY (2011)
Exosomes as Biomarker Treasure Chests for Prostate Cancer
Diederick Duijvesz et al.
EUROPEAN UROLOGY (2011)
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
William J. Catalona et al.
JOURNAL OF UROLOGY (2011)
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
Diagnostic performance of the PCA3 urine test
George Leighton Lee et al.
NATURE REVIEWS UROLOGY (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Scott A. Tomlins et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
Paul F. Pinsky et al.
CLINICAL TRIALS (2010)
Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
Monique J. Roobol et al.
EUROPEAN UROLOGY (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication
Andrew Vickers et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Urine biomarkers in prostate cancer
Guillaume Ploussard et al.
NATURE REVIEWS UROLOGY (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
B. Furusato et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Ultrasensitive Immunosensor for Cancer Biomarker Proteins Using Gold Nanoparticle Film Electrodes and Multienzyme-Particle Amplification
Vigneshwaran Mani et al.
ACS NANO (2009)
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
J. Nilsson et al.
BRITISH JOURNAL OF CANCER (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Oncogenic gene fusions in epithelial carcinomas
John R. Prensner et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram
Felix K. Chun et al.
EUROPEAN UROLOGY (2009)
Glycoproteomics for Prostate Cancer Detection: Changes in Serum PSA Glycosylation Patterns
Danni L. Meany et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
Bo Han et al.
MODERN PATHOLOGY (2009)
ETS rearrangements and prostate cancer initiation
Brett S. Carver et al.
NATURE (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
The use of PCA3 in the diagnosis of prostate cancer
Daphne Hessels et al.
NATURE REVIEWS UROLOGY (2009)
ETS gene fusions in prostate cancer
Jeremy P. Clark et al.
NATURE REVIEWS UROLOGY (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden
Andrew J. Vickers et al.
BMC MEDICINE (2008)
The role of SPINK1 in ETS rearrangement-negative prostate cancers
Scott A. Tomlins et al.
CANCER CELL (2008)
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
Bharathi Laxman et al.
CANCER RESEARCH (2008)
Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
Jianghua Wang et al.
CANCER RESEARCH (2008)
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications
Juan-Miguel Mosquera et al.
CLINICAL CANCER RESEARCH (2008)
Delineation of TMPRSS2-ERG splice variants in prostate cancer
Ying Hu et al.
CLINICAL CANCER RESEARCH (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Electrochemical immunoassay for free prostate specific antigen (f-PSA) using magnetic beads
P. Sarkar et al.
ELECTROANALYSIS (2008)
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Alexander Haese et al.
EUROPEAN UROLOGY (2008)
A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering
Xiong Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
PCA3: A molecular urine assay for predicting prostate biopsy outcome
Ina L. Deras et al.
JOURNAL OF UROLOGY (2008)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
Quantitative, spatial resolution of the epigenetic field effect in prostate cancer
Jyoti Mehrotra et al.
PROSTATE (2008)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate
J. Clark et al.
ONCOGENE (2007)
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy
Leonard S. Marks et al.
UROLOGY (2007)
Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications
Ajay Kumar Gupta et al.
NANOMEDICINE (2007)
Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias
Maisa Yoshimoto et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
Carbon nanotube amplification strategies for highly sensitive immunodetection of cancer biomarkers
Xin Yu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
Jack Groskopf et al.
CLINICAL CHEMISTRY (2006)
Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: Clues for clonal progression in prostate carcinogenesis
R Henrique et al.
MOLECULAR CANCER RESEARCH (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
GF Zheng et al.
NATURE BIOTECHNOLOGY (2005)
The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells
S Wilson et al.
BIOCHEMICAL JOURNAL (2005)
Cancer nanotechnology: Opportunities and challenges
M Ferrari
NATURE REVIEWS CANCER (2005)
DD3PCA3 RNA analysis in urine -: A new perspective for detecting prostate cancer
M Tinzl et al.
EUROPEAN UROLOGY (2004)
Quantitative GSTP1 methylation levels correlate with Gleason grade and tumor volume in prostate needle biopsies
M Zhou et al.
JOURNAL OF UROLOGY (2004)
Femtomolar detection of prostate-specific antigen: An immunoassay based on surface-enhanced Raman scattering and immunogold labels
DS Grubisha et al.
ANALYTICAL CHEMISTRY (2003)
Identification of genes periodically expressed in the human cell cycle and their expression in tumors
ML Whitfield et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
α-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
MA Rubin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Bioassay of prostate-specific antigen (PSA) using microcantilevers
GH Wu et al.
NATURE BIOTECHNOLOGY (2001)
The multiple roles of PTEN in tumor suppression
A Di Cristofano et al.
CELL (2000)
分享论文
